Cinical utility of measuring biologics and human anti-chimeric antibody concentrations in patients with IBD
Not Applicable
Recruiting
- Conditions
- ulcerative colitis, Crohn's disease
- Registration Number
- JPRN-UMIN000005611
- Lead Sponsor
- 1-5-45 Yushima, BUnkyo-ku, Tokyo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Patients without biologics
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison of infliximab concentration and anti-chimeric antibody in patients on remission with those in patients on clinically active
- Secondary Outcome Measures
Name Time Method